1. Home
  2. MDV vs MCRB Comparison

MDV vs MCRB Comparison

Compare MDV & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Modiv Industrial Inc. Class C

MDV

Modiv Industrial Inc. Class C

HOLD

Current Price

$15.24

Market Cap

147.9M

ML Signal

HOLD

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$15.40

Market Cap

140.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDV
MCRB
Founded
2015
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
147.9M
140.7M
IPO Year
2022
2015

Fundamental Metrics

Financial Performance
Metric
MDV
MCRB
Price
$15.24
$15.40
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$14.33
AVG Volume (30 Days)
32.1K
48.7K
Earning Date
03-03-2026
03-12-2026
Dividend Yield
7.75%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.62
Revenue
$47,479,000.00
$351,000.00
Revenue This Year
$0.13
N/A
Revenue Next Year
$0.71
N/A
P/E Ratio
N/A
$24.31
Revenue Growth
N/A
N/A
52 Week Low
$13.62
$6.53
52 Week High
$17.15
$29.98

Technical Indicators

Market Signals
Indicator
MDV
MCRB
Relative Strength Index (RSI) 66.78 46.44
Support Level $14.55 $14.53
Resistance Level $14.92 $16.42
Average True Range (ATR) 0.30 0.85
MACD 0.09 0.05
Stochastic Oscillator 84.70 40.62

Price Performance

Historical Comparison
MDV
MCRB

About MDV Modiv Industrial Inc. Class C

Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Share on Social Networks: